Roche Young Scientist Award 2017 Final Results

Discover the Scientist in You
Roche Young Scientist Award 2017 Final Results

(Hong Kong, 21 May 2017)  Roche Young Scientist Award (RYSA), a programme which runs once every two years, had its final judging and award presentation ceremony at the InnoCentre today. RYSA is a science competition and mentorship programme that aims to encourage secondary school students to use their science acumen and innovative thinking to solve daily health issues. The winning team and their teacher will receive a five-day educational trip to visit Roche headquarters in Switzerland, where they will meet the scientists, view world-class research in action and participate in real laboratory experiments.

The Roche Young Scientist Award was jointly organised by Roche Pharmaceutical and Roche Diagnostics. Mr Andy Barnett, General Manager, Roche Hong Kong Limited, said, “Many scientific inventions start from observations in daily living. We hope RYSA can encourage teenagers who are interested in science to continue their science invention endeavours. I am very pleased to see there are so many talented young scientists, the hope of our future.”

The programme also offered mentorship in the form of a learning and development partnership for the top 15 finalist teams and the School of Science of the Hong Kong University of Science and Technology (HKUST). The British Council also provided science communications training for the teams and their mentors.

Mr Johnny Tse, General Manager, Roche Diagnostics (Hong Kong) Limited, said, “I was very impressed by the students’ attentiveness to the health needs around them and by their innovative ideas. I have been very pleased to see the all-round development of the students, including team building, interpersonal skills and communications, and to see how we are able to contribute to the nurturing of these young scientists through the mentorship programme.”

The winners of RYSA 2017:


St. Paul"s Convent School
Manufacture of Artificial Skin


1st Runner-up

St. Paul’s Convent School
Milk for Everyone: Immobilized Lactase Beads

2nd Runner-up

Po Leung Kuk Ngan Po Ling College
The Synthesis of High Oil-affinity Ester Macromolecule

Most “Liked” Project Award: Healthcare Professionals Vote

St. Paul"s Convent School
Manufacture of Artificial Skin

Most “Liked” Project Award: Audience Vote

Diocesan Girls’ School
Simply Pesticide Free


“Supporting Science in School” Awards

Maryknoll Convent School (Secondary Section)
S.K.H. Li Ping Secondary School
St. Paul’s Convent School
Tsuen Wan Public Ho Chuen Yiu Memorial College


RYSA was launched in Hong Kong in 2012, and this is the third event in the series. Since its inception, over 700 students have participated in the RYSA programme.

Judging panel

  • Mr Andy Barnett, General Manager, Roche Hong Kong Limited
  • Professor Francis Chan, Dean, Faculty of Medicine, The Chinese University of Hong Kong
  • Professor Chow King-lau, Division of Life Science, The Hong Kong University of Science and Technology
  • Mrs Patricia Chu Yeung Pak-yu, Chairman, Hong Kong Anti-Cancer Society
  • Professor John Leong Chi-yan, Chairman, Hong Kong Hospital Authority
  • Mr Johnny Tse, General Manager, Roche Diagnostics (Hong Kong) Limited
  • Professor Yeoh Eng-kiong, Director, The Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong
  • Professor Yuen Kwok-yung, Henry Fok Professor in Infectious Disease, Department of Microbiology, The University of Hong Kong


About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit

All trademarks used or mentioned in this release are protected by law.

For media enquiries, please contact:

Peggie Wong

9813 7753

[email protected]

Eleanor Ng

9469 3000

[email protected]

Winnie Hui

9345 3657

[email protected]